Company demonstrates treatment with intravenous fibroblasts can facilitate remyelination in the brains of mice. Regenerative medicine biotech FibroBiologics is claiming … Continue reading "FibroBiologics hails brain tissue repair breakthrough" The...
Using a mouse model, researchers from UCSF have found that the genes that become activated on the silent X chromosome might explain some sex-dependent differences in cognitive abilities during aging...
Eighteen-month expedition sets out to examine longevity practices and question assumptions behind blue zones model. As debates continue over the … Continue reading "BlueCruise embarks on global voyage in search...
Startup aims for clinical trial of lead candidate in IPF while advancing additional programs targeting CCN proteins. Scandinavian biotech Tribune … Continue reading "Tribune raises €37m to advance fibrosis-targeting therapeutics"...
Company gears up for pivotal trials of AI-developed IPF drug candidate following encouraging Phase 2 data. AI-driven drug discovery powerhouse … Continue reading "Insilico seals unicorn status after landing $110m...
Immorta Bio is developing autologous stem cell and immunotherapy solutions to combat aging and enhance cellular regeneration. Aging is the … Continue reading "Harnessing the power of personalized cell therapy"...
London is the setting for the next edition of a premier global gathering for leaders in longevity research and technology … Continue reading "Founders Longevity Forum London reveals first wave...
Progress in spinal cord injury lays the foundation for regenerative therapies that ‘target aging and chronic disease at a cellular … Continue reading "Cellino’s regenerative medicine tie-up with Matricelf is...
Regenerative medicine startup aims to regenerate damaged tissues, modulate chronic inflammation and extend functional healthspan. Longevity biotech ReParris has launched … Continue reading "ReParris emerges to redefine aging as a...
Biotech gains DSMB approval to escalate dosing as it advances novel organ regeneration therapy for end-stage liver disease. LyGenesis, a … Continue reading "LyGenesis progresses Phase 2a clinical trial in...
